Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-05 1:23 pm Purchase | 2024-12-31 | 13G | Novavax, Inc. NVAX | BlackRock Inc. BLK | 13,450,411 8.400% | 5,014,232 (+59.44%) | Filing History |
| 2024-11-12 4:46 pm Unchanged | 2024-09-30 | 13G | Novavax, Inc. NVAX | VANGUARD GROUP INC | 15,430,034 9.630% | 0 (Unchanged) | Filing History |
| 2024-11-04 1:19 pm Purchase | 2024-09-30 | 13G | Novavax, Inc. NVAX | VANGUARD GROUP INC | 15,430,034 9.630% | 869,980 (+5.98%) | Filing History |
| 2024-07-10 06:16 am Sale | 2024-06-30 | 13G | Novavax, Inc. NVAX | STATE STREET CORP STT | 6,066,179 4.320% | -10,709,696 (-63.84%) | Filing History |
| 2024-06-20 2:35 pm Unchanged | 2024-05-10 | 13G | Novavax, Inc. NVAX | SK Bioscience Co. Ltd. | 6,500,000 4.600% | 0 (Unchanged) | Filing History |
| 2024-05-20 06:09 am Purchase | 2024-05-20 | 13D | Novavax, Inc. NVAX | SHAH CAPITAL MANAGEMENT | 11,031,176 7.900% | 265,000 (+2.46%) | Filing History |
| 2024-05-07 2:43 pm Purchase | 2024-05-06 | 13D | Novavax, Inc. NVAX | SHAH CAPITAL MANAGEMENT | 10,766,176 7.700% | 1,382,841 (+14.74%) | Filing History |
| 2024-04-15 12:18 pm Unchanged | 2024-04-10 | 13D | Novavax, Inc. NVAX | SHAH CAPITAL MANAGEMENT | 9,383,335 6.700% | 0 (Unchanged) | Filing History |
| 2024-04-15 06:00 am Purchase | 2024-04-10 | 13D | Novavax, Inc. NVAX | SHAH CAPITAL MANAGEMENT | 9,383,335 6.700% | 4,832,579 (+106.19%) | Filing History |
| 2024-03-07 4:34 pm Sale | 2024-02-29 | 13G | Novavax, Inc. NVAX | MORGAN STANLEY MS | 2,454,328 1.800% | -4,853,705 (-66.42%) | Filing History |
| 2024-02-13 5:09 pm Purchase | 2023-12-29 | 13G | Novavax, Inc. NVAX | VANGUARD GROUP INC | 14,560,054 12.260% | 5,715,401 (+64.62%) | Filing History |
| 2024-02-09 1:59 pm Purchase | 2023-12-31 | 13G | Novavax, Inc. NVAX | MORGAN STANLEY MS | 7,308,033 6.200% | 7,308,033 (New Position) | Filing History |
| 2024-01-26 4:23 pm Purchase | 2023-12-31 | 13G | Novavax, Inc. NVAX | BlackRock Inc. BLK | 8,436,179 7.100% | 3,627,918 (+75.45%) | Filing History |
| 2024-01-25 08:57 am Purchase | 2023-12-31 | 13G | Novavax, Inc. NVAX | STATE STREET CORP STT | 16,775,875 14.120% | 6,323,363 (+60.50%) | Filing History |
| 2023-08-18 06:08 am Purchase | 2023-08-08 | 13G | Novavax, Inc. NVAX | SK Bioscience Co. Ltd. | 6,500,000 6.400% | 6,500,000 (New Position) | Filing History |
| 2023-05-10 09:10 am Purchase | 2023-04-30 | 13G | Novavax, Inc. NVAX | STATE STREET CORP STT | 10,452,512 12.110% | 4,375,994 (+72.01%) | Filing History |
| 2023-04-27 2:52 pm Purchase | 2023-04-26 | 13D | Novavax, Inc. NVAX | SHAH CAPITAL MANAGEMENT | 4,550,756 5.280% | 4,550,756 (New Position) | Filing History |
| 2023-02-09 11:27 am Purchase | 2022-12-30 | 13G | Novavax, Inc. NVAX | VANGUARD GROUP INC | 8,844,653 10.410% | 852,425 (+10.67%) | Filing History |
| 2023-02-02 12:47 pm Purchase | 2022-12-31 | 13G | Novavax, Inc. NVAX | STATE STREET CORP STT | 6,076,518 7.150% | 6,076,518 (New Position) | Filing History |
| 2023-02-01 4:54 pm Purchase | 2022-12-31 | 13G | Novavax, Inc. NVAX | BlackRock Inc. BLK | 4,808,261 5.700% | 397,500 (+9.01%) | Filing History |